Science Explorer Interactive view Map
Hospital / health system · Toulouse · France

Institut universitaire du cancer de Toulouse Oncopole

In research, Institut universitaire du cancer de Toulouse Oncopole stands highest in Medicine (#3,232 of 10,443 worldwide) and Health Sciences (#4,494 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology and Oncology — Hematology is 26.4× its share of world research.

iuct-oncopole.fr/enROR OpenAlex
World rank, 2022–2025
#10,415
of 28,054 · #14,195 all time
Rank in France
#382
of 1,422
Research works
757
▲ 130% vs 2013–17
Citations
10k
13.4 per fractional work
Top-10% rate
10.7%
record average 16.5%
Open access
37%
world 28%

What is Institut universitaire du cancer de Toulouse Oncopole known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #3,232 of 10,443 11.2%211 #5698
Health SciencesDomain #4,494 of 11,982 10.9%219 #7627

Each strip is that field’s whole ranked pool, with the notch where Institut universitaire du cancer de Toulouse Oncopole sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

What does Institut universitaire du cancer de Toulouse Oncopole specialise in?

Where its research is concentrated relative to its size: Hematology takes 26.4× the share of its output that it takes of world research.

  1. HematologySubfield · 22.1 works26×
  2. OncologySubfield · 38.7 works12×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.07× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.00× its world share, 29 worksBiochemistry, Geneti…Immunology and Microbiology: 3.07× its world share, 8 worksImmunology and Micro…Neuroscience: 0.21× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.45× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.15× its world share, 1 worksChemistryComputer Science: 0.13× its world share, 3 worksComputer ScienceEngineering: 0.08× its world share, 3 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.02× its world share, 0 worksMaterials ScienceMathematics: 0.16× its world share, 0 worksMathematicsPhysics and Astronomy: 0.40× its world share, 2 worksPhysics and AstronomyDentistry: 1.11× its world share, 2 worksDentistryHealth Professions: 0.88× its world share, 6 worksHealth ProfessionsMedicine: 3.98× its world share, 211 worksMedicineNursing: 0.09× its world share, 0 worksNursingArts and Humanities: 0.01× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.15× its world share, 1 worksBusiness, Management…Decision Sciences: 0.27× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.14× its world share, 1 worksEconomics, Econometr…Psychology: 0.14× its world share, 1 worksPsychologySocial Sciences: 0.05× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.0×. Every wedge is a field page.

Who are the top researchers at Institut universitaire du cancer de Toulouse Oncopole?

Ranked on the composite score, Hervé Avet‐Loiseau, Michel Attal and Loïc Ysebaert lead among researchers whose main affiliation is Institut universitaire du cancer de Toulouse Oncopole.

  1. 1 Hervé Avet‐Loiseau France · #8,615 worldwide 806 citations · 104 works
  2. 2 Michel Attal France · #51,903 worldwide 352 citations · 86 works
  3. 3 Loïc Ysebaert France · #181,688 worldwide 105 citations · 38 works
  4. 4 Slimane Zerdoud France · #343,163 worldwide 68 citations · 22 works
  5. 5 Charlotte Vaysse France · #428,848 worldwide 45 citations · 22 works
  6. 6 Jean Vial France · #596,237 worldwide 15 citations · 20 works
  7. 7 V. Sibaud France · #661,092 worldwide 81 citations · 51 works
  8. 8 Cécile Borel France · #702,625 worldwide 24 citations · 21 works
  9. 9 Pierre Bories France · #767,729 worldwide 24 citations · 21 works
  10. 10 Aurore Perrot France · #791,094 worldwide 110 citations · 72 works
All ranked researchers at Institut universitaire du cancer de Toulouse Oncopole

Which keywords describe research at Institut universitaire du cancer de Toulouse Oncopole?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Chemotherapy, Immunotherapy, Radiotherapy, Rituximab, Clinical Practice Guidelines, Lymphoma and Genetic Mutations.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Prognostic Factors32▲ 26×14 topics
  2. Chemotherapy30▲ 16×23 topics
  3. Immunotherapy24▲ 12×18 topics
  4. Epidemiology15▲ 1.41×57 topics
  5. Radiotherapy15▲ 14×12 topics
  6. Rituximab14▲ 35×4 topics
  7. Clinical Practice Guidelines13▲ 8.4×13 topics
  8. Lymphoma12▲ 28×4 topics
  9. Genetic Mutations12▲ 10×17 topics
  10. PET Imaging12▲ 25×4 topics
  11. Cancer11▲ 3.1×34 topics
  12. Tumor Microenvironment11▲ 9.2×8 topics
  13. Survival Analysis11▲ 14×7 topics
  14. Minimal Residual Disease11▲ 56×2 topics
  15. Clinical Trials10▲ 5.5×11 topics
  16. Staging System10▲ 58×2 topics
  17. Targeted Therapy9▲ 15×5 topics
  18. Hematopoietic Stem Cells9▲ 37×3 topics
  19. Classification8▲ 6.7×6 topics
  20. Metastasis8▲ 8.9×11 topics
  21. Molecular Classification8▲ 20×4 topics
  22. Biomarkers8▲ 4.3×11 topics
  23. Proteasome Inhibitors8▲ 42×2 topics
  24. Diagnosis Criteria8▲ 83×1 topic
  25. International Myeloma Working Group8▲ 83×1 topic
  26. Cancer Immunotherapy8▲ 19×3 topics
  27. Molecular Characterization8▲ 15×5 topics
  28. Molecular Profiling8▲ 27×3 topics
  29. Neoadjuvant Therapy8▲ 12×5 topics
  30. Gene Expression Profiling7▲ 33×2 topics
  31. Therapeutic Targets7▲ 17×5 topics
  32. Breast Cancer7▲ 11×11 topics
  33. Chronic Lymphocytic Leukemia7▲ 55×1 topic
  34. Genomic Aberrations7▲ 55×1 topic
  35. Immune Checkpoint Blockade7▲ 23×1 topic
  36. PD-1 and PD-L17▲ 23×1 topic
  37. Genetic Pathogenesis6▲ 44×1 topic
  38. Hodgkin's Lymphoma6▲ 44×1 topic
  39. Acute Myeloid Leukemia6▲ 43×1 topic
  40. Tumor Regression6▲ 20×2 topics

Which research topics does Institut universitaire du cancer de Toulouse Oncopole publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers and Lymphoma Diagnosis and Treatment.

Multiple Myeloma Researc…8Multiple Myeloma Research and Treatments: 8 fractional worksChronic Lymphocytic Leuk…7Chronic Lymphocytic Leukemia Research: 7 fractional worksCancer Immunotherapy and…7Cancer Immunotherapy and Biomarkers: 7 fractional worksLymphoma Diagnosis and T…6Lymphoma Diagnosis and Treatment: 6 fractional worksAcute Myeloid Leukemia Research: 6 fractional worksCAR-T cell therapy research: 6 fractional worksChronic Myeloid Leukemia…4Chronic Myeloid Leukemia Treatments: 4 fractional worksSarcoma Diagnosis and Treatment: 4 fractional worksProtein Degradation and Inhibitors: 4 fractional worksCancer Genomics and Diagnostics: 3 fractional works
HematologyGeneticsOncologyPathology and Forensic Medicine3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Multiple Myeloma Research and Treatments Hematology 8 works
  2. 2 Chronic Lymphocytic Leukemia Research Genetics 7 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 7 works
  4. 4 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 6 works
  5. 5 Acute Myeloid Leukemia Research Hematology 6 works
  6. 6 CAR-T cell therapy research Oncology 6 works
  7. 7 Chronic Myeloid Leukemia Treatments Hematology 4 works
  8. 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 4 works
  9. 9 Protein Degradation and Inhibitors Molecular Biology 4 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 3 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.2%not open62.8%

World: 28% of research is openly available.

with international co-authors25.3%domestic only74.7%

World: 19% is written across borders.

How has Institut universitaire du cancer de Toulouse Oncopole's research output changed?

Output in 2018–2022 was 130% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Toulouse

All research institutions in Toulouse

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.